Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Merck KGaA acquires JSR chromatography business

 April 2, 2026

Pharmaceutical Business Review

This follows the company’s signing of a definitive agreement in October 2025 to acquire the business.

M&A / DealsRead full story

Post navigation

Biocytogen and Sihuan partner to advance new therapeutics for weight loss →
← Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com